179 related articles for article (PubMed ID: 11157725)
1. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice.
Konstantinides S; Schäfer K; Thinnes T; Loskutoff DJ
Circulation; 2001 Jan; 103(4):576-83. PubMed ID: 11157725
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice.
Eitzman DT; Westrick RJ; Nabel EG; Ginsburg D
Blood; 2000 Jan; 95(2):577-80. PubMed ID: 10627465
[TBL] [Abstract][Full Text] [Related]
3. Vitronectin inhibits the thrombotic response to arterial injury in mice.
Fay WP; Parker AC; Ansari MN; Zheng X; Ginsburg D
Blood; 1999 Mar; 93(6):1825-30. PubMed ID: 10068653
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic phenotype of mice with a combined deficiency in plasminogen activator inhibitor 1 and vitronectin.
Koschnick S; Konstantinides S; Schäfer K; Crain K; Loskutoff DJ
J Thromb Haemost; 2005 Oct; 3(10):2290-5. PubMed ID: 16194205
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.
Zhu Y; Carmeliet P; Fay WP
Circulation; 1999 Jun; 99(23):3050-5. PubMed ID: 10368124
[TBL] [Abstract][Full Text] [Related]
6. Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine carotid arteries.
Peng L; Bhatia N; Parker AC; Zhu Y; Fay WP
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):934-9. PubMed ID: 12067901
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model.
de Waard V; Arkenbout EK; Carmeliet P; Lindner V; Pannekoek H
Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):1978-83. PubMed ID: 12482822
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice.
Zhu Y; Farrehi PM; Fay WP
Circulation; 2001 Jun; 103(25):3105-10. PubMed ID: 11425776
[TBL] [Abstract][Full Text] [Related]
9. Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.
Wu J; Peng L; McMahon GA; Lawrence DA; Fay WP
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1565-70. PubMed ID: 19574558
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin.
Luo M; Ji Y; Luo Y; Li R; Fay WP; Wu J
J Thromb Haemost; 2017 Dec; 15(12):2451-2460. PubMed ID: 29028290
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices.
Garg N; Goyal N; Strawn TL; Wu J; Mann KM; Lawrence DA; Fay WP
J Thromb Haemost; 2010 Aug; 8(8):1847-54. PubMed ID: 20492459
[TBL] [Abstract][Full Text] [Related]
12. Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury: a potential progenitor of restenosis.
Sawa H; Lundgren C; Sobel BE; Fujii S
J Am Coll Cardiol; 1994 Dec; 24(7):1742-8. PubMed ID: 7963123
[TBL] [Abstract][Full Text] [Related]
13. Enhanced thrombosis in atherosclerosis-prone mice is associated with increased arterial expression of plasminogen activator inhibitor-1.
Schafer K; Müller K; Hecke A; Mounier E; Goebel J; Loskutoff DJ; Konstantinides S
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2097-103. PubMed ID: 14512369
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 from bone marrow-derived cells suppresses neointimal formation after vascular injury in mice.
Schäfer K; Schroeter MR; Dellas C; Puls M; Nitsche M; Weiss E; Hasenfuss G; Konstantinides SV
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1254-9. PubMed ID: 16514083
[TBL] [Abstract][Full Text] [Related]
15. Augmented arterial wall expression of type-1 plasminogen activator inhibitor induced by thrombosis.
Sawa H; Fujii S; Sobel BE
Arterioscler Thromb; 1992 Dec; 12(12):1507-15. PubMed ID: 1450183
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism.
Obi AT; Diaz JA; Ballard-Lipka NL; Roelofs KJ; Farris DM; Lawrence DA; Wakefield TW; Henke PK
J Thromb Haemost; 2014 Aug; 12(8):1353-63. PubMed ID: 24943740
[TBL] [Abstract][Full Text] [Related]
17. Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice.
Kawasaki T; Dewerchin M; Lijnen HR; Vermylen J; Hoylaerts MF
Blood; 2000 Jul; 96(1):153-60. PubMed ID: 10891445
[TBL] [Abstract][Full Text] [Related]
18. Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation.
Reheman A; Gross P; Yang H; Chen P; Allen D; Leytin V; Freedman J; Ni H
J Thromb Haemost; 2005 May; 3(5):875-83. PubMed ID: 15733060
[TBL] [Abstract][Full Text] [Related]
19. Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator.
Schäfer K; Konstantinides S; Riedel C; Thinnes T; Müller K; Dellas C; Hasenfuss G; Loskutoff DJ
Circulation; 2002 Oct; 106(14):1847-52. PubMed ID: 12356640
[TBL] [Abstract][Full Text] [Related]
20. Local plasminogen activator inhibitor type 1 overexpression in rat carotid artery enhances thrombosis and endothelial regeneration while inhibiting intimal thickening.
Hasenstab D; Lea H; Clowes AW
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):853-9. PubMed ID: 10712413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
